Ryanair bets on quick post-Covid recovery in 2021
Ryanair, Europe’s biggest no-frills airline, is set for its first loss since 2009, but expects a rapid rebound in 2021. Is it being too optimistic? Matthew Partridge reports
Ryanair says it is undergoing the “most challenging” year in its 35-year history, say Kalyeena Makortoff and Gwyn Topham in The Guardian. Europe’s biggest no-frills carrier is heading for an annual loss of nearly €1bn (£880m) in the year to 1 April. The decision of many families to stay at home, combined with the new wave of travel restrictions announced in the weeks before Christmas, cut traffic by 78% year-on-year in the final three months of 2020. Further restrictions announced since then, along with European lockdowns, put it on track for a full-year net loss of between €850m and €950m. That would mark the airline’s first year in the red since the global financial crisis in 2009.
This isn’t the first time in the last year that CEO Michael O’Leary has had to lower expectations, says Robert Lea in The Times. In fact, he has had to reduce predicted passenger numbers no fewer than seven times, from 100 million in May to between 26 million and 30 million just after Christmas. The airline now thinks that the final number could be even lower, with “more risk towards the lower end of the range”.
Rivals will suffer more
Things may be tough at present, but Ryanair is not alone in its misery, says Philip Georgiadis in the Financial Times. European airlines “are bracing themselves for a tough few months as governments try to stop people travelling to contain the spread of new variants of the virus”. EasyJet said last week that it “would fly just a tenth of its normal schedule in the first quarter of 2021”. Ryanair is also better placed than its rivals to weather the storm as it has “one of the strongest balance sheets and lowest costs in the industry”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
O’Leary may essentially have written off the two months to the end of March, but he is far more upbeat about Ryanair’s next fiscal year, says Simon Calder in the Independent. He is not only confident that growth “will soon return” as the virus recedes, allowing it to “rapidly restore schedules” and “recover lost traffic”, but he also predicts that there will be “extraordinary pent-up demand”. As a result, Ryanair is already planning to expand in Italy and northern France, while reopening its base at Shannon in the west of Ireland in the summer of 2021.
Not so fast, says Simon Foy in the Daily Telegraph. O’Leary is clearly hoping that Ryanair can “capitalise on the many growth opportunities” after the pandemic and take advantage of the fact that competitor airlines “have substantially cut capacity or failed”.
Still, his vision of a “dramatic recovery” in airline travel this summer looks a touch optimistic given that the EU’s inoculation programme “remains in turmoil”, hampering their ability to loosen travel restrictions. And even the British government has warned that summer 2021 may be “very similar” to the last one.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Pension vs property: which option provides the best income for your retirement?
News With the cost of a comfortable retirement on the rise, future retirees need to weigh up which strategy offers the best returns. But is a pension a better bet than property?
By Henry Sandercock Published
-
The industry at the heart of global technology
The semiconductor industry powers key trends such as artificial intelligence, says Rupert Hargreaves
By Rupert Hargreaves Published
-
The industry at the heart of global technology
The semiconductor industry powers key trends such as artificial intelligence, says Rupert Hargreaves
By Rupert Hargreaves Published
-
Three emerging Asian markets to invest in
Professional investor Chetan Sehgal of Templeton Emerging Markets Investment Trust tells us where he’d put his money
By Chetan Sehgal Published
-
What to consider before investing in small-cap indexes
Small-cap index trackers show why your choice of benchmark can make a large difference to long-term returns
By Cris Sholto Heaton Published
-
Why space investments are the way to go for investors
Space investments will change our world beyond recognition, UK investors should take note
By Merryn Somerset Webb Published
-
Time to tap into Africa’s mobile money boom
Favourable demographics have put Africa on the path to growth when it comes to mobile money and digital banking
By Rupert Hargreaves Published
-
M&S is back in fashion: but how long can this success last?
M&S has exceeded expectations in the past few years, but can it keep up the momentum?
By Rupert Hargreaves Published
-
The end of China’s boom
Like the US, China too got fat on fake money. Now, China's doom is not far away.
By Bill Bonner Published
-
Magic mushrooms — an investment boom or doom?
Investing in these promising medical developments might see you embark on the trip of a lifetime.
By Bruce Packard Published